Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Graft Versus Host Disease

Autologous peripheral blood stem cell transplantation with induction of autologous graft-versus-host disease in acute myeloid leukemia

Bone Marrow Transplantation volume 32, pages 889–895 (2003)Cite this article

Summary:

We studied whether the induction of autologous graft-versus-host disease (GVHD) has an antileukemic effect and consequently increases the survival of patients undergoing autologous peripheral blood stem cell transplantation (PBSCT). In all, 22 acute myeloid leukemia patients with favorable and intermediate cytogenetic risk, in their first complete remission, were administered cyclosporine c.i.v. from day 0 to day +28 at a dose of 3.0 mg/kg per day and interferon-γ (IFN-γ) at 0.025 mg/m2 s.c. every other day from day +14 to day +42 following autologous PBSCT. Natural-killer (NK)-cell activity assays and skin biopsies were performed. Successful engraftment was achieved in all patients at a median of 13 days without significant additional toxicity. Histologically confirmed cutaneous GVHD developed in 12 patients, and NK-cell activity was significantly augmented after autologous PBSCT in those patients (P=0.03). After a median follow-up duration of 37.7 months (range, 7.3–72.8), the 3-year disease-free survival (DFS) and overall survival (OS) rates were 64.4 and 73.1%, respectively, without significant correlation with GVHD status or augmentation of NK-cell activity. These data suggest that the administration of cyclosporine and IFN-γ following autologous PBSCT improves OS and DFS, which may be attributable to the antileukemic effect, although no difference in survival could be demonstrated between cutaneous GVHD-positive and -negative groups.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Horowitz MM, Gale RP, Sondel PM et al. Graft-versus-leukemia reactions after bone marrow transplantation. Blood 1990; 75: 555–562.

    CAS  PubMed  Google Scholar 

  2. Kersey JH, Weisdorf D, Nesbit NE . Comparison of autologous and allogeneic bone marrow transplantation for treatment of high-risk refractory acute lymphoblastic leukemia. N Engl J Med 1987; 317: 461–467.

    Article  CAS  PubMed  Google Scholar 

  3. Weiden PL, Flournoy N, Thomas ED et al. Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts. N Engl J Med 1979; 300: 1068–1073.

    Article  CAS  PubMed  Google Scholar 

  4. Jones RJ, Ambinder RF, Piantadosi S, Santos GW . Evidence of a graft-versus-lymphoma effect associated with allogeneic bone marrow transplantation. Blood 1991; 77: 649–653.

    CAS  PubMed  Google Scholar 

  5. Glazier A, Tutschka PJ, Farmer ER, Santos GW . Graft-versus-host disease in cyclosporine treated rats after syngeneic autologous bone marrow reconstitution. J Exp Med 1983; 158: 1–8.

    Article  CAS  PubMed  Google Scholar 

  6. Jones RJ, Vogelsang GB, Hess AD et al. Induction of graft-versus-host disease after autologous bone marrow transplantation. Lancet 1989; 1: 754–757.

    Article  CAS  PubMed  Google Scholar 

  7. Baron F, Gothot A, Salmon JP et al. Clinical course and predictive factors for cyclosporin-induced autologous graft-versus-host disease after autologous haematopoietic stem cell transplantation. Br J Haematol 2000; 111: 745–753.

    CAS  PubMed  Google Scholar 

  8. Yeager AM, Vogelsang GB, Jones RJ et al. Induction of cutaneous graft-versus-host disease by administration of cyclosporine to patients undergoing autologous bone marrow transplantation for acute myeloid leukemia. Blood 1992; 79: 3031–3035.

    CAS  PubMed  Google Scholar 

  9. Vogelsang G, Bitton R, Piantadosi S et al. Immune modulation in autologous bone marrow transplantation: cyclosporine and gamma-interferon trial. Bone Marrow Transplant 1999; 24: 637–640.

    Article  CAS  PubMed  Google Scholar 

  10. Miura Y, Ueda M, Zeng W et al. Induction of autologous graft-versus-host disease with cyclosporine A after peripheral blood stem cell transplantation: analysis of factors affecting induction. J Allergy Clin Immunol 2000; 106 (1 Part 2): S51–S57.

    Article  CAS  PubMed  Google Scholar 

  11. Geller RB, Esa AH, Beschorner WE et al . Successful in vitro graft-versus-tumor effect against an Ia-bearing tumor using cyclosporine-induced syngeneic graft-versus-host disease in the rat. Blood 1989; 74: 1165–1171.

    CAS  PubMed  Google Scholar 

  12. Hess AD, Thoburn C, Horwitz L . Promiscuous recognition of major histocompatibility complex class II determinants in cyclosporine-induced syngeneic graft-versus-host disease: specificity of cytolytic effector T cells. Transplantation 1998; 65: 785–792.

    Article  CAS  PubMed  Google Scholar 

  13. Fischer AC, Ruvolo PP, Burt R et al. Characterization of the autoreactive T cell repertoire in cyclosporin-induced syngeneic graft-versus-host disease: a highly conserved repertoire mediates autoaggression. J Immunol 1995; 154: 3713–3725.

    CAS  PubMed  Google Scholar 

  14. Dolei A, Capobianchi MR, Ameglio F . Human interferon-gamma enhances the expression of class I and class II major histocompatibility complex products in neoplastic cells more effectively than interferon-alpha and interferon-beta. Infect Immunol 1983; 40: 172–176.

    CAS  Google Scholar 

  15. Noga SJ, Horwitz L, Kim H et al. Interferon-gamma potentiates the antitumor effect of cyclosporine-induced autoimmunity. J Hematother 1992; 1: 75–84.

    Article  CAS  PubMed  Google Scholar 

  16. Kennedy MJ, Vogelsang GB, Jones RJ et al. Phase I trial of interferon gamma to potentiate cyclosporine-induced graft-versus-host disease in women undergoing autologous bone marrow transplantation for breast cancer. J Clin Oncol 1994; 12: 249–257.

    Article  PubMed  Google Scholar 

  17. van der Wall E, Horn T, Bright E et al. Autologous graft-versus-host disease induction in advanced breast cancer: role of peripheral blood progenitor cells. Br J Cancer 2000; 83: 1405–1411.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Glass B, Uharek L, Zeis M et al. Graft-versus-leukaemia activity can be predicted by natural cytotoxicity against leukaemia cells. Br J Haematol 1996; 93: 412–420.

    Article  CAS  PubMed  Google Scholar 

  19. Jiang YZ, Barrett AJ, Goldman JM, Mavroudis DA . Association of natural killer cell immune recovery with a graft-versus-leukemia effect independent of graft-versus-host disease following allogeneic bone marrow transplantation. Ann Hematol 1997; 74: 1–6.

    Article  CAS  PubMed  Google Scholar 

  20. Flanagan DL, Jennings CD, Bryson JS . Th1 cytokines and NK cells participate in the development of murine syngeneic graft-versus-host disease. J Immunol 1999; 163: 1170–1177.

    CAS  PubMed  Google Scholar 

  21. Grimwade D, Walker H, Oliver F et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood 1998; 92: 2322–2333.

    CAS  PubMed  Google Scholar 

  22. Slovak ML, Kopecky KJ, Cassileth PA et al. Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study. Blood 2000; 96: 4075–4083.

    CAS  PubMed  Google Scholar 

  23. Lerner KG, Kao GF, Storb R et al. Histopathology of graft-versus-host reaction in human recipients of marrow from HLA-matched sibling donors. Transplant Proc 1974; 6: 367–371.

    CAS  PubMed  Google Scholar 

  24. Cohen LM, Skopicki DK, Harrist TJ, Clark Jr WH . Noninfectious vesiculobullous and vesiculopustular disease. In: Elder D (ed.) Lever's Histopathology of the Skin, 8th edn Lippincott-Raven: Philadelphia, New York, 1997, pp 209–252.

    Google Scholar 

  25. Yoon HL, Singh KP, Ratner S, Reiners Jr JJ . Phorbol ester effects on splenic lymphocyte composition and cytotoxic T cell activity of SSIN mice; a strain deficient in CD8+ T cells. Carcinogenesis 1996; 17: 2617–2624.

    Article  CAS  PubMed  Google Scholar 

  26. Gale RP, Horowitz MM . Graft-versus-leukemia in bone marrow transplantation. The Advisory Committee of the International Bone Marrow Transplant Registry. Bone Marrow Transplant 1990; 6 (Suppl. 1): 94–97.

    PubMed  Google Scholar 

  27. Slavin S, Ackerstein A, Naparstek E et al. The graft-versus-leukemia (GVL) phenomenon: is GVL separable from GVHD? Bone Marrow Transplant 1990; 6: 155–161.

    CAS  PubMed  Google Scholar 

  28. van der Straaten HM, Fijnheer R, Dekker AW et al. Relationship between graft-versus-host disease and graft-versus-leukaemia in partial T cell-depleted bone marrow transplantation. Br J Haematol 2001; 114: 31–35.

    Article  CAS  PubMed  Google Scholar 

  29. Miura Y, Thoburn CJ, Bright EC et al. Cytokine and chemokine profiles in autologous graft-versus-host disease (GVHD): interleukin 10 and interferon gamma may be critical mediators for the development of autologous GVHD. Blood 2002; 100: 2650–2658.

    Article  CAS  PubMed  Google Scholar 

  30. Linker CA . Autologous stem cell transplantation for acute myeloid leukemia. Bone Marrow Transplant 2003; 31: 731–738.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Hematology/Oncology, Department of Medicine, Seoul, Korea

    J Park, M H Lee, S H Park, S-H Lee, K-E Lee, J O Park, K Kim, C W Jung, Y-H Im, W K Kang & K Park

  2. Hematopoietic Cell Transplantation Center, Cancer Center, Seoul, Korea

    M H Lee, H Lee, K Kim & C W Jung

  3. Department of Internal Medicine, Ilsan Paik Hospital, Inje University College of Medicine, Goyang, Korea

    H R Lee

  4. Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

    Y-H Ko

Authors
  1. J Park
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M H Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H R Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S H Park
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S-H Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. K-E Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. H Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. J O Park
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. K Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. C W Jung
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Y-H Im
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. W K Kang
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Y-H Ko
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. K Park
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M H Lee.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Park, J., Lee, M., Lee, H. et al. Autologous peripheral blood stem cell transplantation with induction of autologous graft-versus-host disease in acute myeloid leukemia. Bone Marrow Transplant 32, 889–895 (2003). https://doi.org/10.1038/sj.bmt.1704251

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1704251

Keywords

This article is cited by

Search

Advanced search

Quick links